文献速递血栓与止血

F8基因新剪接变异导致重型血友病A的功能鉴定

Identification and functional characterization of a novel splicing variant in the F8 coagulation gene causing severe hemophilia A.
PubMed 文献 · J Thromb Haemost · 2020-01-01

本研究在一名产生抑制物的重型血友病A患者中鉴定出F8同义变异c.6273G>A,该变异影响第21外显子剪接位点。通过患者巨噬细胞、外显子捕获及小鼠模型证实该变异导致两种异常剪接产物,使FVIII蛋白滞留于内质网并缺失C2结构域,部分恢复FVIII活性且未出现抗FVIII抗体。

要点

  • F8同义变异c.6273G>A可导致异常剪接并影响FVIII蛋白功能与抑制物产生。
  • 该变异产生两种剪接异构体,分别保留部分内含子21或跳过外显子21。
  • 携带FVIII突变体的慢病毒载体在HA小鼠中部分恢复FVIII活性且未诱发抑制物。

核心结论

  • F8同义变异c.6273G>A通过异常剪接影响FVIII转录、活性及病理结局。
  • 研究强调需加深对F8突变功能后果及其与抑制物产生和替代治疗疗效关联的认识。

研究设计与样本

  • 从一名产生抑制物的重型血友病A患者外周血分离单核细胞并分化为巨噬细胞。
  • 通过外显子捕获评估突变第21外显子剪接,构建慢病毒载体转导CHO细胞并注射B6/129 HA小鼠。
  • FVIII活性用活化部分凝血活酶时间评估,抗FVIII抗体和FVIII抗原用ELISA检测。

主要发现

  • 患者巨噬细胞中FVIII主要滞留于内质网周围。
  • 外显子捕获显示产生两种异构体:一种保留部分内含子21,另一种跳过外显子21。
  • 两种变异体预测在C1结构域截断FVIII,并在患者中检测到。
  • 转导两种FVIII转录本的CHO细胞证实蛋白滞留且缺失C2结构域。
  • 注射携带FVIII突变体慢病毒的HA小鼠部分恢复FVIII活性,未出现抗FVIII抗体。

临床怎么用

  • 对重型血友病A患者应关注F8同义变异的功能后果及其与抑制物产生的关联。
  • F8变异功能研究有助于理解替代治疗疗效差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We have identified a synonymous F8 variation in a severe hemophilia A (HA) patient who developed inhibitors following factor VIII (FVIII) prophylaxis. The unreported c.6273 G > A variant targets the consensus splicing site of exon 21. OBJECTIVES: To determine the impact of c.6273 G > A nucleotide substitution on F8 splicing and its translated protein. METHODS: Patient peripheral blood mononuclear cells were isolated and differentiated into monocyte-derived macrophages (MDMs). FVIII distribution in cell compartments was evaluated by immunofluorescence. The splicing of mutated exon 21 was assessed by exon trapping. Identified FVIII splicing variants were generated by site-directed mutagenesis, inserted into a lentiviral vector (LV) to transduce Chinese hamster ovary (CHO) cells, and inject into B6/129 HA-mice. FVIII activity was assessed by activated partial thromboplastin time, whereas anti-FVIII antibodies and FVIII antigen, by ELISA. RESULTS: HA-MDMs demonstrated a predominant retention of FVIII around the endoplasmic reticulum. Exon trapping revealed the production of two isoforms: one retaining part of intron 21 and the other skipping exon 21. These variants, predicted to truncate FVIII in the C1 domain, were detected in the patient. CHO cells transduced with the two FVIII transcripts confirmed protein retention and absence of the C2 domain. HA mice injected with LV carrying FVIII mutants, partially recovered FVIII activity without the appearance of anti-FVIII antibodies. CONCLUSIONS: Herein, we demonstrate the aberrant impact of a FVIII synonymous mutation on its transcription, activity, and pathological outcomes. Our data underline the importance of increasing the knowledge regarding the functional consequences of F8 mutations and their link to inhibitor development and an effective replacement therapy.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Famà R, Borroni E, Zanolini D, et al. Identification and functional characterization of a novel splicing variant in the F8 coagulation gene causing severe hemophilia A. J Thromb Haemost. 2020. PMID: 32078252. doi:10.1111/jth.14779

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。